Korean vivax malaria. I. Natural history and response to chloroquine.
Explore the source record for details and available documents.
Chloroquine↗
Biomedical subjects
A S ALVING
Publications and source records attributed to A S ALVING.
Korean vivax malaria. II. Curative treatment with pamaquine and primaquine.
Explore the source record for details and available documents.
Aminoquinolines↗
Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily.
Explore the source record for details and available documents.
Antimalarials↗
Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days.
Explore the source record for details and available documents.
Antimalarials↗
Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency.
Explore the source record for details and available documents.
Antimalarials↗
Mass therapy of subclinical vivax malaria with primaquine.
Explore the source record for details and available documents.
Malaria↗
Cure of Korean vivax malaria with pamaquine and primaquine.
Explore the source record for details and available documents.
Aminoquinolines↗
Toxicity of primaquine in Caucasians.
Explore the source record for details and available documents.
Malaria↗
Toxicity of primaquine in Negroes.
Explore the source record for details and available documents.
Black People↗
Physiological changes during perfusion of the isolated intestinal loop in chronic uremia.
Explore the source record for details and available documents.
Humans↗
Malignant hypertension.
Explore the source record for details and available documents.
Blood Pressure↗
Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.
Explore the source record for details and available documents.
Aminoquinolines↗
Alterations of cerebral functions in pheochromocytoma.
Explore the source record for details and available documents.
History↗